Abstract:BackgroundUsher syndrome (USH) is the most common disease causing combined deafness and blindness. It is predominantly an autosomal recessive genetic disorder with occasionally digenic cases. Molecular diagnosis of USH patients is important for disease management. Few studies have tried to find the genetic cause of USH in Chinese patients. This study was designed to determine the mutation spectrum of Chinese USH patients.MethodsWe applied next generation sequencing to characterize the mutation spectrum in 67 independent Chinese families with at least one member diagnosed with USH. Blood was collected at Peking Union Medical College Hospital. This cohort is one of the largest USH cohorts reported. We utilized customized panel and whole exome sequencing, variant analysis, Sanger validation and segregation tests to find disease causing mutations in these families.ResultsWe identified biallelic disease causing mutations in known USH genes in 70 % (49) of our patients. As has been previously reported, MYO7A is the most frequently mutated gene in our USH type I patients while USH2A is the most mutated gene in our USH type II patients. In addition, we identify mutations in CLRN1, DFNB31, GPR98 and PCDH15 for the first time in Chinese USH patients. Together, mutations in CLRN1, DNFB31, GPR98 and PCDH15 account for 11.4 % of disease in our cohort. Interestingly, although the spectrum of disease genes is quite similar between our Chinese patient cohort and other patient cohorts from different (and primarily Caucasian) ethnic backgrounds, the mutations themselves are dramatically different. In particular, 76 % (52/68) of alleles found in this study have never been previously reported. Interestingly, we observed a strong enrichment for severe protein truncating mutations expected to have severe functional consequence on the protein in USH II patients compared to the reported mutation spectrum in RP patients, who often carry partial protein truncating mutations.ConclusionsOur study provides the first comprehensive genetic characterization of a large collection of Chinese USH patients. Up to 90 % of USH patients have disease caused by mutations in known USH disease genes. By combining NGS-based molecular diagnosis and patient clinical information, a more accurate diagnosis, prognosis and personalized treatment of USH patients can be achieved.

Amplicon Targeted Resequencing for SLC2A9 and SLC22A12 Identified Novel Mutations in Hypouricemia Subjects

Genotype and Phenotype of Renal Hypouricemia: A Single-Center Study from China

Renal Hypouricemia Caused by Novel Compound Heterozygous Mutations in the SLC22A12 Gene: a Case Report with Literature Review.

Common Variants in the SLC28A2 Gene Are Associated with Serum Uric Acid Level and Hyperuricemia and Gout in Han Chinese

Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese

Association of an Intronic SNP of SLC2A9 Gene with Serum Uric Acid Levels in the Chinese Male Han Population by High-Resolution Melting Method

Donor-derived Hypouricemia in Irrelevant Recipients Caused by Kidney Transplantation.

Association between SLC2A9 gene and SLC22A12 gene and hyperuricemia

High-Resolution Melting Analysis for the Rapid Detection of an Intronic Single Nucleotide Polymorphism in Slc22a12 in Male Patients with Primary Gout in China

Molecular analysis of a SNP in SCL2A9 and uric acid levels in Chinese male gout patients

Comprehensive molecular diagnosis of 67 Chinese Usher syndrome probands: high rate of ethnicity specific mutations in Chinese USH patients

Serum Uric Acid Levels Are Associated with Polymorphisms in the SLC2A9, SF1, and GCKR Genes in a Chinese Population.

Association study of SLC22A12 gene rs893006 and SLC2A9 gene rs11942223 with hyperuricemia

Polymorphisms in GCKR , SLC17A1 and SLC22A12 Were Associated with Phenotype Gout in Han Chinese Males: a Case–control Study

Replication of Gout/Urate Concentrations GWAS Susceptibility Loci Associated with Gout in a Han Chinese Population

A Study of Correlation Between Uric Acid Transporter Gene SLC16A9 Polymorphism and Hyperuricemia in Uyghur

Identification of Novel and Rare CYP21A2 Variants in Chinese Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Associations between the SLC22A12 gene and gout susceptibility: a meta-analysis.

Locus-specific stratification and prioritization unveil high risk genes underlying hyperuricemia

Targeted Exome Sequencing Identified Novel Ush2a Mutations In Usher Syndrome Families

Recurrent exercise-induced acute kidney injury by idiopathic renal hypouricemia with a novel mutation in the SLC2A9 gene and literature review